N4 Pharma CEO Q&A Now LIVE
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce the release of an investor Q&A from CEO, Nigel Theobald.
Investors were invited to submit questions on the October 2024 New Corporate Presentation, full slide deck here.
The Q&A response is now live on N4 Pharma's interactive investor hub here: https://investors.n4pharma.com/link/0y5jle.
Any additional follow up questions from investors will be answered by CEO Nigel Theobald in the coming days via the hub.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.